Gene therapy treatment for AMD in clinical trials

Phase 1 clinical trials on a new gene therapy to treat age-related macular degeneration are currently underway in multiple locations around the country. Early results from the trials are offering promising results and researchers hope gene therapy for wet macular degeneration will be available within the next 3 to 5 years. This new therapy would […]

New Drug for Dry Macular Degeneration?

A new drug to treat the “dry” form of macular degeneration is currently undergoing clinical trials. Allegro Ophthalmics has reported encouraging results from the phase 2 study of Risuteganib. The small phase 2 study involved 40 patients and was conducted over a 28 week period with participants receiving 2 injections. Half of the patients received […]

New Drug Approved for Wet Macular Degeneration

Novartis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved it’s new drug, Beovu®, for the treatment of wet age-related macular degeneration (AMD). Beovu® (brolucizumab) recently completed two late-stage clinical trials, which tested the safety and efficacy of the intravitreal injection. Wet AMD is an eye condition which can lead to a […]

Which Sunglasses Best Protect Your Vision?

While sunglasses are often deemed to be no more than a fashion accessory, the impact that they have on your vision is critically important. The choice of your sunglasses is every bit as important as your choice of sun block for your skin. The National Eye Institute reports that UV radiation can damage proteins in […]

Air pollution a factor in macular degeneration

Study results recently published in the Journal of Investigative Medicine point to a link between air pollutants and an increased risk of developing age-related macular degeneration. This is the first study to show a notable association between macular degeneration and high levels of atmospheric pollution. The study was conducted in Taiwan and involved tracking levels […]

Medication for Dry Macular Degeneration Coming Soon?

While Wet Macular Degeneration has enjoyed the fruits of great research and effective medications, the more common Dry Macular Degeneration has no similar medications for treatment. That might be changing soon. The company, Allegro Ophthalmics, LLC, has developed the molecule, Risuteganib, which the company states is effective against the oxidative stress in the retina that […]

Which medication is best for wet macular degeneration?

Johns Hopkins University School of Medicine researchers studied the ocular as well as systemic effects that three anti-VEGF therapies had on patients. Pegatanib, ranibizumab and bevacizumab were all compared to patients who received no anti-VEGF treatments Researchers evaluated specific studies from databases and focused on 16 randomized controlled trials that had a total of 6347 […]

Gene therapy used to treat AMD

A surgeon at the John Radcliffe Hospital in the UK successfully injected a synthetic gene into a patient’s eye in the hope of stopping the progression of age-related macular degeneration. The patient, Janet Osborne, is the first person to receive the gene therapy in the trial that is being conducted at the John Radcliffe Hospital […]

Eye calcifications raise AMD risk

Researchers at the University of Alabama at Birmingham in collaboration with the Queen’s University Belfast made a breakthrough discovery regarding age-related macular degeneration (AMD). Researchers discovered that calcified nodules in the retina are linked to an increase risk for the progression to advanced AMD. Researchers studied clinical imaging in patients as well as molecular analysis […]

Savoring spinach – Possible sight-saver?

The cartoon character Popeye loved his spinach and spinach may have been more than a muscle builder. A recent study has found that eating leafy greens, such as spinach, which are high in nitrates, could help reduce your risk of developing age-related macular degeneration. Spinach, lettuce, cabbage and beetroot all examples of vegetables that are high […]